AstraZeneca: Making 'Inspiring Ideas' a Reality?

ECCR's report on pharmaceuticals multinational AstraZeneca. Key findings and issues:

• significant progress in developing corporate responsibility policies and mechanisms
• improvements in reporting
• significant room to improve transparency, especially regarding lobbying
• apparent gaps in policy on human and indigenous peoples’ rights and on joint ventures
• lack of policy clarity regarding access to medicines in developing countries, drugs testing for paediatric use, communication with local communities, employment, and relationships with suppliers
• concerns about advertising standards
• analysis based on the Bench Marks
• the company’s written response to issues raised in the report is included.
  

Published 2003. Hard copy: ECCR members - £8 / €9 / $13. Non-members - £16 / €18 / $26. Order form.

Download a copy of the full report (pdf).